Gaois

Search direction

Search mode

Filter results

Collections

4 results in 2 documents

  1. #2050570

    Próiseas bitheolaíoch is ea trasnaíocht RNA ina gcuireann móilíní RNA bacainn ar léiriú nó aistriú géine trí mhóilíní mRNA spriocdhírithe a neodrú.

    RNA interference is a biological process in which RNA molecules inhibit gene expression or translation, by neutralising targeted mRNA molecules.

    Commission Delegated Regulation (EU) 2021/805 of 8 March 2021 amending Annex II to Regulation (EU) 2019/6 of the European Parliament and of the Council (Text with EEA relevance)

  2. #2714591

    an fhéidearthacht go dtarlódh aistriú géine i ndáil le frithsheasmhacht in aghaidh antaibheathach ó Pseudomonas chlororaphis tréithchineál MA 342 chuig miocrorgánaigh eile i gcomhréir le SANTE/2020/12260 .

    the potential for gene transfer of antibiotic resistance from Pseudomonas chlororaphis strain MA 342 to other micro-organisms in accordance with SANTE/2020/12260.

    Commission Implementing Regulation (EU) 2023/223 of 27 January 2023 renewing the approval of the active substance Pseudomonas chlororaphis strain MA 342 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance)

  3. #2050116

    Déanfar measúnú cruinn ar éifeachtaí díobhálacha féideartha ar shláinte an duine agus ar an gcomhshaol, a d’fhéadfadh teacht chun cinn mar thoradh ar aistriú géine ó OGManna chuig orgánaigh eile nó mar thoradh ar mhodhnuithe géiniteacha, ar bhonn cás ar chás.

    Potential adverse effects on human health and the environment, which may occur through gene transfer from GMOs to other organisms or arise from genetic modifications, shall be accurately assessed on a case-by-case basis.

    Commission Delegated Regulation (EU) 2021/805 of 8 March 2021 amending Annex II to Regulation (EU) 2019/6 of the European Parliament and of the Council (Text with EEA relevance)

  4. #2714538

    Ina theannta sin, chun an mhuinín a mhéadú sa chonclúid gur diomaibhseach nó an-íseal atá an riosca do dhaoine agus don chomhshaol tar éis teagmháil le Pseudomonas chlororaphis tréithchineál MA 342, ba cheart don iarratasóir faisnéis dheimhnitheach a sholáthar a mhéid a bhaineann le sainaithint agus tréithriú Pseudomonas chlororaphis tréithchineál MA 342, an mheitibilít DDR agus an fhéidearthacht go dtarlódh aistriú géine i ndáil le frithsheasmhacht in aghaidh antaibheathach ó Pseudomonas chlororaphis tréithchineál MA 342 chuig miocrorgánaigh eile.

    In addition, in order to increase the confidence in the conclusion that the risk for human beings and the environment following the exposure to Pseudomonas chlororaphis strain MA 342 is negligible or very low, the applicant should provide confirmatory information as regards the identification and characterisation of Pseudomonas chlororaphis strain MA 342, the metabolite DDR and the potential for gene transfer of antibiotic resistance from Pseudomonas chlororaphis strain MA 342 to other micro-organisms.

    Commission Implementing Regulation (EU) 2023/223 of 27 January 2023 renewing the approval of the active substance Pseudomonas chlororaphis strain MA 342 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance)